The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug
Open accessAbstract
Improvement of quality of life and survival of cancer patients will be greatly enhanced by the development of highly effective drugs to selectively kill malignant cells. Artemisinin and its analogs are naturally occurring antimalarials which have shown potent anticancer activity. In primary cancer cultures and cell lines, their antitumor actions were by inhibiting cancer proliferation, metastasis, and angiogenesis. In xenograft models, exposure to artemisinins substantially reduces tumor volume and progression. However, the rationale for the use of artemisinins in anticancer therapy must be addressed by a greater understanding of the underlying mechanisms involved in their cytotoxic effects. The primary targets for artemisinin and the chemical base for its preferential effects on heterologous tumor cells need yet to be elucidated. The aim of this paper is to provide an overview of the recent advances and new development of this class of drugs as potential anticancer agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
Qinghaosu (Artemisinin): an Antimalarial Drug from China
Klayman, D. L. (1985) · Science · doi:10.1126/science.3887571 · Cited by 2,186
Tumor metastasis: mechanistic insights and clinical challenges
Steeg, P. S. (2006) · Nature Medicine · doi:10.1038/nm1469 · Cited by 2,134
To cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
CYCLINS AND CELL CYCLE CHECKPOINTS
Johnson, D. G., & Walker, C. L. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.295 · Cited by 719
The Molecular Mechanism of Action of Artemisinin—The Debate Continues
O’Neill, P. M., Barton, V. E., & Ward, S. A. (2010) · Molecules · doi:10.3390/molecules15031705 · Cited by 595
The anti-malarial artesunate is also active against cancer
Efferth, T., Dunstan, H., Sauerbrey, A., Miyachi, H., & Chitambar, C. (2001) · International Journal of Oncology · doi:10.3892/ijo.18.4.767 · Cited by 564
Uren, A. G., Wong, L., Pakusch, M., Fowler, K. J., Burrows, F. J., Vaux, D. L., & Choo, K. H. A. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00769-7 · Cited by 527
Molecular Modes of Action of Artesunate in Tumor Cell Lines
Efferth, T., Sauerbrey, A., Olbrich, A., Gebhart, E., Rauch, P., Weber, H. O., Hengstler, J. G., Halatsch, M.-E., Volm, M., Tew, K. D., et al. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.2.382 · Cited by 428
2011: the immune hallmarks of cancer
Cavallo, F., De Giovanni, C., Nanni, P., Forni, G., & Lollini, P.-L. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-010-0968-0 · Cited by 415
Charman, S. A., Arbe-Barnes, S., Bathurst, I. C., Brun, R., Campbell, M., Charman, W. N., Chiu, F. C. K., Chollet, J., Craft, J. C., Creek, D. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015762108 · Cited by 373
Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion
Klonis, N., Crespo-Ortiz, M. P., Bottova, I., Abu-Bakar, N., Kenny, S., Rosenthal, P. J., & Tilley, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104063108 · Cited by 333
Self-citationHou, J., Wang, D., Zhang, R., & Wang, H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0197 · Cited by 320
Increased Tolerance to Artemisinin in Plasmodium falciparum Is Mediated by a Quiescence Mechanism
Witkowski, B., Lelièvre, J., López Barragán, M. J., Laurent, V., Su, X.-Z., Berry, A., & Benoit-Vical, F. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01636-09 · Cited by 317
Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action
Meshnick, S. R., Thomas, A., Ranz, A., Xu, C.-M., & Pan, H.-Z. (1991) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(91)90062-b · Cited by 303
Hsiao, W., & Liu, L. (2010) · Planta Medica · doi:10.1055/s-0030-1250186 · Cited by 302
Cancer invasion and metastasis: changing views
Duffy, M., McGowan, P., & Gallagher, W. (2008) · The Journal of Pathology · doi:10.1002/path.2282 · Cited by 302
Cytotoxicity of Artemisinin-Related Endoperoxides to Ehrlich Ascites Tumor Cells
Woerdenbag, H. J., Moskal, T. A., Pras, N., Malingré, T. M., El-Feraly, F. S., Kampinga, H. H., & Konings, A. W. T. (1993) · Journal of Natural Products · doi:10.1021/np50096a007 · Cited by 278
de Vries, P. J., & Dien, T. K. (1996) · Drugs · doi:10.2165/00003495-199652060-00004 · Cited by 277
Bostwick, D. G., Alexander, E. E., Singh, R., Shan, A., Qian, J., Santella, R. M., Oberley, L. W., Yan, T., Zhong, W., Jiang, X., et al. (2000) · Cancer · doi:10.1002/1097-0142(20000701)89:1<123::aid-cncr17>3.0.co;2-9 · Cited by 269
Efferth, T. (2007) · Planta Medica · doi:10.1055/s-2007-967138 · Cited by 269
Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron
Efferth, T., Benakis, A., Romero, M. R., Tomicic, M., Rauh, R., Steinbach, D., Häfer, R., Stamminger, T., Oesch, F., Kaina, B., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.023 · Cited by 266
Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia Cells
Efferth, T., Giaisi, M., Merling, A., Krammer, P. H., & Li-Weber, M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000693 · Cited by 256
Artemisinins: mechanisms of action and potential for resistance
KRISHNA, S., UHLEMANN, A., & HAYNES, R. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.07.001 · Cited by 243
Hamacher-Brady, A., Stein, H. A., Turschner, S., Toegel, I., Mora, R., Jennewein, N., Efferth, T., Eils, R., & Brady, N. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.210047 · Cited by 230
Possible modes of action of the artemisinin-type compounds
Olliaro, P. L., Haynes, R. K., Meunier, B., & Yuthavong, Y. (2001) · Trends in Parasitology · doi:10.1016/s1471-4922(00)01838-9 · Cited by 228
Haynes, R. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606776743129 · Cited by 224 · cited 1×
“Artemisone, a second-generation artemisinin, has shown improved pharmacokinetic properties including longer half-life and lower toxicity [13].”
Toxicity of the antimalarial artemisinin and its dervatives
Efferth, T., & Kaina, B. (2010) · Critical Reviews in Toxicology · doi:10.3109/10408441003610571 · Cited by 219
Artemisinin induces apoptosis in human cancer cells.
Singh, N. P., & Lai, H. C. (2004) · PubMed · Cited by 218
The iron metabolism of neoplastic cells: Alterations that facilitate proliferation?
Kwok, J. C., & Richardson, D. R. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00213-x · Cited by 215 · cited 1×
“reported that leukemia (CCRFCEM) and astrocytoma (U373) cells express TfR in 95% and 43% of the cell population, whereas normal monocytes only account for approximately 1% [42, 43].”
Das, U. N. (2002) · PubMed · Cited by 202
Mercer, A. E., Maggs, J. L., Sun, X.-M., Cohen, G. M., Chadwick, J., O'Neill, P. M., & Park, B. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610375200 · Cited by 192
Nakase, I., Lai, H., Singh, N. P., & Sasaki, T. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.09.003 · Cited by 190
Anticancer activities of artemisinin and its bioactive derivatives
Firestone, G. L., & Sundar, S. N. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001239 · Cited by 185
In Vitro and In Vivo Activities of Synthetic Trioxolanes against Major Human Schistosome Species
Xiao, S.-H., Keiser, J., Chollet, J., Utzinger, J., Dong, Y., Endriss, Y., Vennerstrom, J. L., & Tanner, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01537-06 · Cited by 184
Heme as Trigger and Target for Trioxane-Containing Antimalarial Drugs
Meunier, B., & Robert, A. (2010) · Accounts of Chemical Research · doi:10.1021/ar100070k · Cited by 183
Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin
Lai, H., & Singh, N. P. (1995) · Cancer Letters · doi:10.1016/0304-3835(94)03716-v · Cited by 183
Chen, T., Li, M., Zhang, R., & Wang, H. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00360.x · Cited by 180
Artesunate in the treatment of metastatic uveal melanoma - first experiences
Berger, T., Dieckmann, D., Efferth, T., Schultz, E., Funk, J.-O., Baur, A., & Schuler, G. (2005) · Oncology Reports · doi:10.3892/or.14.6.1599 · Cited by 176
Transferrin receptor: Its biological significance
May, W. S., & Cuatrecasas, P. (1985) · The Journal of Membrane Biology · doi:10.1007/bf01871086 · Cited by 175
Cell cycle control as a basis for cancer drug development (Review).
McDonald, E. R., & El-Deiry, W. S. (2000) · International Journal of Oncology · doi:10.3892/ijo.16.5.871 · Cited by 172
Wang, S.-J., Gao, Y., Chen, H., Kong, R., Jiang, H.-C., Pan, S.-H., Xue, D.-B., Bai, X.-W., & Sun, B. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.01.001 · Cited by 163
Willoughby, J. A., Sundar, S. N., Cheung, M., Tin, A. S., Modiano, J., & Firestone, G. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m804491200 · Cited by 162
Artemisinin derivatives: toxic for laboratory animals, safe for humans?
Gordi, T., & Lepist, E.-I. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2003.12.009 · Cited by 162
Mercer, A. E., Copple, I. M., Maggs, J. L., O'Neill, P. M., & Park, B. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.144188 · Cited by 161
Du, J.-H., Zhang, H.-D., Ma, Z.-J., & Ji, K.-M. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1095-5 · Cited by 159
Dihydroartemisinin Is Cytotoxic to Papillomavirus-Expressing Epithelial Cells In vitro and In vivo
Disbrow, G. L., Baege, A. C., Kierpiec, K. A., Yuan, H., Centeno, J. A., Thibodeaux, C. A., Hartmann, D., & Schlegel, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1216 · Cited by 154
Dihydroartemisinin is an inhibitor of ovarian cancer cell growth
Jiao, Y., Ge, C., Meng, Q., Cao, J., Tong, J., & Fan, S. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00612.x · Cited by 146
Lü, Y., Chen, T., Qu, J., et al. (2009) · Journal of Biomedical Science · doi:10.1186/1423-0127-16-16 · Cited by 130
Crespo, M. D. P., Avery, T. D., Hanssen, E. G., Fox, E., Robinson, T. V., Valente, P., Taylor, D. K., & Tilley, L. M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00609-07 · Cited by 130
Zhou, H., Wang, W., Wu, G.-D., Lee, J. H., & Li, A. (2007) · Vascular Pharmacology · doi:10.1016/j.vph.2007.05.002 · Cited by 129
Anfosso, L., Efferth, T., Albini, A., & Pfeffer, U. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500371 · Cited by 127
Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo
Chen, H., Sun, B., Pan, S., Jiang, H., & Sun, X. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3283212ade · Cited by 125
Antimalarial dihydroartemisinin also inhibits angiogenesis
Chen, H., Zhou, H., Wang, W., & Wu, G. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0751-4 · Cited by 125
The pharmacology of cancer resistance.
O'Connor, R. A. (2007) · PubMed · Cited by 123
Rasheed, S. A. K., Efferth, T., Asangani, I. A., & Allgayer, H. (2010) · International Journal of Cancer · doi:10.1002/ijc.25315 · Cited by 122
Hur, E., Kim, H.-H., Choi, S. M., Kim, J. H., Yim, S., Kwon, H. J., Choi, Y., Kim, D. K., Lee, M.-O., & Park, H. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.975 · Cited by 120
Lu, J., Chen, S.-M., Zhang, X., Ding, J., & Meng, L. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9481-8 · Cited by 119
Neurotoxic Mode of Action of Artemisinin
Schmuck, G., Röhrdanz, E., Haynes, R. K., & Kahl, R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.821-827.2002 · Cited by 119
Zu-yi, Z. (2008) · Journal of Chinese Integrative Medicine · doi:10.3736/jcim20080206 · Cited by 118
Creek, D. J., Charman, W. N., Chiu, F. C. K., Prankerd, R. J., Dong, Y., Vennerstrom, J. L., & Charman, S. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01033-07 · Cited by 115
Riganti, C., Doublier, S., Viarisio, D., Miraglia, E., Pescarmona, G., Ghigo, D., & Bosìa, A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00117.x · Cited by 114
Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines
Michaelis, M., Kleinschmidt, M. C., Barth, S., Rothweiler, F., Geiler, J., Breitling, R., Mayer, B., Deubzer, H. E., Witt, O., Kreuter, J., et al. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.08.013 · Cited by 110
Antimalaria studies on Qinghaosu.
(1979) · PubMed · Cited by 108
Stockwin, L. H., Han, B., Yu, S. X., Hollingshead, M. G., ElSohly, M. A., Gul, W., Slade, D., Galal, A. M., & Newton, D. L. (2009) · International Journal of Cancer · doi:10.1002/ijc.24496 · Cited by 105
Posner, G. H., Oh, C. H., Gerena, L., & Milhous, W. K. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00091a014 · Cited by 104
Hwang, Y. P., Yun, H. J., Kim, H. G., Han, E. H., Lee, G. W., & Jeong, H. G. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.02.003 · Cited by 101
SPC3042: a proapoptotic survivin inhibitor
Hansen, J. B., Fisker, N., Westergaard, M., Kjaerulff, L. S., Hansen, H. F., Thrue, C. A., Rosenbohm, C., Wissenbach, M., Ørum, H., & Koch, T. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0161 · Cited by 99
Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria*
Ashton, M., Sy, N. D., Hướng, N. V., Gordi, T., Hai, T. N., Huong, D. X., Niêu, N. T., & Công, L. D. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90044-3 · Cited by 98
Antitumor Activity of Novel Deoxoartemisinin Monomers, Dimers, and Trimer
Jung, M., Lee, S., Ham, J., Lee, K., Kim, H., & Kim, S. K. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020119d · Cited by 98
Beekman, A. C., Wierenga, P. K., Woerdenbag, H. J., et al. (1998) · Planta Medica · doi:10.1055/s-2006-957533 · Cited by 97
Jeyadevan, J. P., Bray, P. G., Chadwick, J., Chadwick, A. E., Byrne, A., Ward, S. A., Park, B. K., Williams, D. P., Cosstick, R., Davies, J. D., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030974c · Cited by 96
Chemosensitization of Prostate Cancer by Modulating Bcl-2 Family Proteins
Karnak, D. M., & Xu, L. (2010) · Current Drug Targets · doi:10.2174/138945010791170888 · Cited by 95
Dihydroartemisinin Induces Apoptosis by a Bak-Dependent Intrinsic Pathway
Handrick, R., Ontikatze, T., Bauer, K.-D., Freier, F., Rübel, A., Dürig, J., Belka, C., & Jendrossek, V. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0051 · Cited by 90
Heme Mediates Cytotoxicity from Artemisinin and Serves as a General Anti-Proliferation Target
Zhang, S., & Gerhard, G. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007472 · Cited by 90
He, Q., Shi, J., Shen, X., An, J., Sun, H., Wang, L., Hu, Y.-J., Sun, Q. Y., Fu, L., Sheikh, M. S., et al. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.10.11552 · Cited by 89
Kissinger, E. A., Hien, T. T., Hùng, N. T., Nam, N. C., Tuyen, N. L., Dinh, B. V., Mann, C., Phu, N. H., Loc, P. P., Simpson, J. A., et al. (2000) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2000.63.48 · Cited by 89
Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro
Kim, S. J., Kim, M. S., Lee, J. W., Lee, C. H., Yoo, H., Shin, S. H., Park, M.-J., & Lee, S. H. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0052-x · Cited by 88
Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells
Morrissey, C. M., Gallis, B. M., Solazzi, J. W., Kim, B. J., Gulati, R., Vakar‐Lopez, F., Goodlett, D. R., Vessella, R. L., & Sasaki, T. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328336f57b · Cited by 88
Youns, M., Efferth, T., Reichling, J., Fellenberg, K., Bauer, A. S., & Hoheisel, J. D. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.014 · Cited by 88
Zhou, H., Zhang, J., Li, A., Wang, Z., & Lou, X.-E. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1129-z · Cited by 87
Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway
Wang, S.-J., Sun, B., Cheng, Z.-X., Zhou, H.-X., Gao, Y., Kong, R., Chen, H., Jiang, H.-C., Pan, S.-H., Xue, D.-B., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1643-7 · Cited by 86
Reungpatthanaphong, P., & Mankhetkorn, S. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.1555 · Cited by 86
Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds
Lai, H. C., Sasaki, T., & Singh, N. P. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.5.995 · Cited by 82
Cabello, C. M., Lamore, S. D., Bair, W. B., Qiao, S., Azimian, S., Lesson, J. L., & Wondrak, G. T. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9676-7 · Cited by 82
The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells
Mu, D., Zhang, W., Chu, D.-L., Liu, T., Xie, Y., Fu, E., & Jin, F. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0517-5 · Cited by 81
Case report of a laryngeal squamous cell carcinoma treated with artesunate
Singh, N., & Verma, K. (2002) · Archive of oncology · doi:10.2298/aoo0204279s · Cited by 80
Development of Resistance towards Artesunate in MDA-MB-231 Human Breast Cancer Cells
Bachmeier, B. E., Fichtner, I., Killian, P. H., Kronski, E., Pfeffer, U., & Efferth, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020550 · Cited by 78
Case Report of a Pituitary Macroadenoma Treated With Artemether
Singh, N. P., & Panwar, V. K. (2006) · Integrative Cancer Therapies · doi:10.1177/1534735406295311 · Cited by 77
Lu, J., Meng, L.-H., Shankavaram, U. T., Zhu, C.-H., Tong, L.-J., Chen, G., Lin, L.-P., Weinstein, J. N., & Ding, J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.02.016 · Cited by 75
Horwedel, C., Tsogoeva, S. B., Wei, S., & Efferth, T. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100404t · Cited by 73
Opsenica, I., Opsenica, D., Smith, K. S., Milhous, W. K., & Šolaja, B. A. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701417a · Cited by 73
Weifeng, T., Feng, S., Xiangji, L., Su, C., Zhiquan, Q., Huazhong, Z., Peining, Y., Yong, Y., Wu, M., Xiaoqing, J., et al. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.07.003 · Cited by 69
Liu, W. M., Gravett, A. M., & Dalgleish, A. G. (2010) · International Journal of Cancer · doi:10.1002/ijc.25707 · Cited by 67
Huang, X.-J., Ma, Z.-Q., Zhang, W., Lu, Y., & Wei, E.-Q. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.6.0011 · Cited by 67
Alagbala, A. A., McRiner, A. J., Borstnik, K., Labonte, T., Chang, W., D’Angelo, J. G., Posner, G. H., & Foster, B. A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060803i · Cited by 66
Artemisinin-transferrin conjugate retards growth of breast tumors in the rat.
Lai, H. C., Nakase, I., Lacoste, E., Singh, N. P., & Sasaki, T. (2009) · Anticancer Research · Cited by 65
Buommino, E., Baroni, A., Canozo, N., Petrazzuolo, M., Nicoletti, R., VOZZA, A., & Tufano, M. A. (2008) · Investigational New Drugs · doi:10.1007/s10637-008-9188-2 · Cited by 61
Anti-tumor effects of dihydroartemisinin on human osteosarcoma
Ji, Y., Zhang, Y.-C., Pei, L., Shi, L., Yan, J., & Ma, X.-H. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0716-6 · Cited by 61
Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells.
Singh, N. P., & Lai, H. C. (2005) · PubMed · Cited by 60
Wu, J., Hu, D. G., Yang, G., Zhou, J., Yang, C., Gao, Y., & Zhu, Z. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23114 · Cited by 56
Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties
Soomro, S. A., Langenberg, T., Mahringer, A., Konkimalla, V. B., Horwedel, C., Holenya, P., Brand, A., Cetin, C., Fricker, G., Dewerchin, M. A., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01120.x · Cited by 55
Xu, Q., Li, Z., Peng, H., Sun, Z., Cheng, R.-L., Ye, Z., & Li, W. (2011) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1000373 · Cited by 55
Subcellular Localization of a Fluorescent Artemisinin Derivative to Endoplasmic Reticulum
Liu, Y., Lok, C., Ko, B. C. B., Shum, T. Y.-T., Wong, M., & Che, C. (2010) · Organic Letters · doi:10.1021/ol902890j · Cited by 54
Toxic brainstem encephalopathy after artemisinin treatment for breast cancer
Panossian, L. A., Garga, N. I., & Pelletier, D. (2005) · Annals of Neurology · doi:10.1002/ana.20620 · Cited by 54
Gravett, A. M., Liu, W. M., Krishna, S., Chan, W., Haynes, R. K., Wilson, N., & Dalgleish, A. G. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1355-4 · Cited by 52
Li, S., Xue, F., Cheng, Z., Yang, X., Wang, S., Geng, F., & Pan, L. (2009) · International Journal of Hematology · doi:10.1007/s12185-009-0409-z · Cited by 52
Ultrastructural alterations in adult Schistosoma mansoni caused by artemether
Xiao, S.-H., Binggui, S., Utzinger, J., Chollet, J., & Tanner, M. (2002) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762002000500023 · Cited by 51
Artemisinin Inhibits Tumor Lymphangiogenesis by Suppression of Vascular Endothelial Growth Factor C
Wang, J., Zhang, B., Guo, Y., Li, G., Xie, Q., Zhu, B., Gao, J., & Chen, Z. (2008) · Pharmacology · doi:10.1159/000148261 · Cited by 50
Antineoplastic drugs that interfere with iron metabolism in cancer cells
Head, J. F., Wang, F., & Elliott, R. L. (1997) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(96)00010-6 · Cited by 49
Dihydroartemisinin Potentiates the Cytotoxic Effect of Temozolomide in Rat C6 Glioma Cells
Huang, X.-J., Li, C.-T., Zhang, W., Lu, Y., Fang, S., & Wei, E.-Q. (2008) · Pharmacology · doi:10.1159/000125673 · Cited by 49
Lü, Y., Chen, T., Wang, X., & Li, L. (2010) · Journal of Biomedical Optics · doi:10.1117/1.3481141 · Cited by 49
Local and Global Paratropic and Diatropic Ring Currents in Pyrene and Its Cyclopenta-Fused Congeners
Steiner, E. H., Fowler, P. W., Jenneskens, L. W., & Havenith, R. W. A. (2002) · European Journal of Organic Chemistry · doi:10.1002/1099-0690(20021)2002:1<113::aid-ejoc113>3.0.co;2-n · Cited by 48
Li, L., Zhang, H., Yuan, S., Yang, D., Wang, L., & Sun, Z. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.041 · Cited by 48
Factors determining sensitivity or resistance of tumor cell lines towards artesunate
Sertel, S., Eichhorn, T., Sieber, S., Sauer, A., Weiß, J., Plinkert, P. K., & Efferth, T. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.02.002 · Cited by 43
Preparation of Bicyclic 1,2,4-Trioxanes from γ,δ-Unsaturated Ketones
Ramirez, A. P., Thomas, A. M., & Woerpel, K. A. (2009) · Organic Letters · doi:10.1021/ol8022853 · Cited by 42
Ferreira, I. D., Lopes, D., Martinelli, A., Ferreira, C., do Rosário, V. E., & Cravo, P. (2007) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01789.x · Cited by 37
Synthesis of tricyclic arteannuin-like compounds
Jefford, C. W., Velarde, J., & Bernardinelli, G. H. (1989) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)80724-3 · Cited by 34
Mu, D., Qi, H. M., Chen, W., et al. (2007) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2007.29.1.1063493 · Cited by 34
Wu, Z., Gao, C.-W., Wu, Y.-G., et al. (2009) · Integrative Cancer Therapies · doi:10.1177/1534735408330714 · Cited by 34
Chai่jaroenkul, W., Viyanant, V., Mahavorasirikul, W., & Na-Bangchang, K. (2011) · PubMed · Cited by 32
Galal, A. M., Ross, S. A., ElSohly, M. A., ElSohly, H. N., El‐Feraly, F. S., Ahmed, M. S., & McPhail, A. T. (2002) · Journal of Natural Products · doi:10.1021/np0104065 · Cited by 31
Li, Q., Weina, P. J., & Milhous, W. K. (2007) · Current Drug Therapy · doi:10.2174/157488507781695649 · Cited by 30
Longhi, A., Porcu, E., Petracchi, S., Versari, M., Conticini, L., & Bacci, G. (2000) · Cancer · Cited by 30
Winn Aung, U., Sogawa, C., Furukawa, T., & Saga, T. (2011) · PubMed · Cited by 30
NMR Studies on Novel Antitumor Drug Candidates, Deoxoartemisinin and Carboxypropyldeoxoartemisinin
Lee, C., Hong, H., Shin, J. S., Jung, M., Shin, I., Yoon, J., & Lee, W. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3086 · Cited by 29
Novel Endoperoxide Antimalarials: Synthesis, Heme Binding, and Antimalarial Activity
Taylor, D. K., Avery, T. D., Greatrex, B. W., Tiekink, E. R. T., Macreadie, I. G., Macreadie, P. I., Humphries, A. D., Kalkanidis, M., Fox, E., Klonis, N., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0305319 · Cited by 28
Feng, T., Guantai, E. M., Nell, M. J., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.03.090 · Cited by 23
Neurotoxicity and Toxicokinetics of Artelinic Acid Following Repeated Oral Administration in Rats
Si, Y., Li, Q., Xie, L. H., Bennett, K., Weina, P. J., Mog, S. R., & Johnson, T. O. (2007) · International Journal of Toxicology · doi:10.1080/10915810701582913 · Cited by 19
Noori, S., Hassan, Z. M., Taghikhani, M., Rezaei, B., & Habibi, Z. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.11.002 · Cited by 17
Longhi, A., Porcu, E., Petracchi, S., Versari, M., Conticini, L., & Bacci, G. (2000) · Cancer · Cited by 10
Cited by
Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies
Zhou, Q., Meng, Y., Li, D., Yao, L., Le, J., Liu, Y., Sun, Y., Zeng, F., Chen, X., & Deng, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01769-5 · Cited by 890
FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation
Gaschler, M. M., Andia, A. A., Liu, H., Csuka, J. M., Hurlocker, B., Vaiana, C. A., Heindel, D. W., Zuckerman, D. S., Bos, P. H., Reznik, E., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0031-6 · Cited by 735
Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics
Vangijzegem, T., Stanicki, D., & Laurent, S. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1554647 · Cited by 548
Advances in Pharmacological Activities of Terpenoids
Yang, W., Chen, X., Li, Y., Guo, S., Wang, Z., & Yu, X. (2020) · Natural Product Communications · doi:10.1177/1934578x20903555 · Cited by 496
Sesquiterpene Lactones from Artemisia Genus: Biological Activities and Methods of Analysis
Ivanescu, B., Miron, A., & Corciova, A. (2015) · Journal of Analytical Methods in Chemistry · doi:10.1155/2015/247685 · Cited by 201
“These pleiotropic effects can account for effectiveness of artemisinin compounds in multidrug resistant types of cancer [25].”
Background
Metadata
- Authors
- Crespo-Ortiz, M. P., & Wei, M. Q.
- Venue
- Journal of Biomedicine and Biotechnology
- Publisher
- Hindawi Limited
- Published
- 2012
- Volume
- 2012
- Pages
- 1-18
- ISSN
- 1110-7243 (ISSN-L)
- 1110-7251
- OpenAlex
- W2050853222
- Cited by
- 382
- References
- 133
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.